Φορτώνει......
Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting
Breast cancer stem cells (BCSCs), also known as breast cancer initiating cells, are reported to be responsible for the initiation, progression, therapeutic resistance, and relapse of breast cancer. Conventional therapeutic agents mainly kill the bulk of breast tumor cells and fail to eliminate BCSCs...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Nanomedicine |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7914063/ https://ncbi.nlm.nih.gov/pubmed/33654398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S282110 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|